Paul van Dun

reMYND NV engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders. Its drug and development unit focuses on innovative, disease-modifying drugs for treating degenerative disorders. The company was founded by Fred Van Leuven, Stefaan Wera and Joris Winderickx in 2002 and is headquartered in Leuven, Belgium.

Gemma Frisius Fonds K.U. Leuven (GFF) is an Independent Venture Capital firm founded in 1997 as a joint venture between Katholieke Universiteit Leuven, KBC Group and BNP Paribas Group. Gemma Frisius K.U. Leuven is headquartered in Leuven.

Innovation Fund is a venture capital firm founded in 2015. The firm headquartered located in Schaerbeek, Belgium.

VersaSense NV provides wireless Internet of Things (IoT) products and services that reduce the total cost of ownership for industrial sensing and control systems. Its MicroPnP product line provides a standards-based solution that reduces the cost of acquiring, building, and operating highly scalable wireless sensing and control systems. The company is headquartered in Leuven, Belgium.

Regionaal Ziekenhuis Heilig Hart Tienen VZW is a regional hospital located in Tienen, Belgium. The hospital provides various medical services such as consultation, examination, radiological examinations, and nursing departments. Patients can also find information about hospital costs, agreements regarding care and accommodation, and inclusion of costs on their invoice. The hospital encourages patients to share their experiences to improve patient care. The hospital was founded in 1971, and Hans Struyven has been the CEO of the Belgian company since 2007.

Nexuzhealth NV is a Belgian company that provides a centralized electronic patient record system and related services. The private company is based in Hasselt, Belgium. Additionally, the company offers the Klinisch Werkstation (KWS) support to efficiently manage data flows in hospitals, improve processes, gain medical insights, and encourage collaboration within and between healthcare institutions. Founded in 2016, the company allows patients to access their medical records, appointments, invoices, and personal information online through the mynexuzhealth website and app.

Anethon is a medical device company developing second generation biomimetic cardiovascular prostheses. These devices are class III implants encompassing blood vessels, patches and heart valves. The company, a Flanders based spin-off of the KULeuven, was incorporated in July 2011, to exploit IP and know-how generated by its founders, Prof Willem Flameng, a key opinion leader in cardiac surgery, and Geofrey De Visscher, PhD.